LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 1 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 1. - Dataset (ID:20309)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 33.78 | 771.67 | 3887 | 3499 | 1.1107 | 1.0986 | MN20160304_L01 | K18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 36.00 | 771.67 | 3624 | 3884 | 0.9329 | 0.9413 | MN20160304_L01 | D09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 36.00 | 771.67 | 4315 | 3884 | 1.1108 | 1.0922 | MN20160304_L01 | K18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 38.22 | 771.67 | 4047 | 4299 | 0.9412 | 0.9517 | MN20160304_L01 | D09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 38.22 | 771.67 | 4850 | 4299 | 1.1280 | 1.0996 | MN20160304_L01 | K18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 40.44 | 771.67 | 4490 | 4738 | 0.9476 | 0.9593 | MN20160304_L01 | D09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 40.44 | 771.67 | 5280 | 4738 | 1.1143 | 1.0844 | MN20160304_L01 | K18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 42.67 | 771.67 | 4939 | 5155 | 0.9580 | 0.9689 | MN20160304_L01 | D09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 42.67 | 771.67 | 5777 | 5155 | 1.1205 | 1.0848 | MN20160304_L01 | K18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 44.89 | 771.67 | 5299 | 5541 | 0.9562 | 0.9688 | MN20160304_L01 | D09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 44.89 | 771.67 | 6151 | 5541 | 1.1100 | 1.0747 | MN20160304_L01 | K18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 47.11 | 771.67 | 5722 | 5941 | 0.9631 | 0.9746 | MN20160304_L01 | D09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 47.11 | 771.67 | 6703 | 5941 | 1.1282 | 1.0836 | MN20160304_L01 | K18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 49.33 | 771.67 | 6034 | 6392 | 0.9439 | 0.9625 | MN20160304_L01 | D09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 49.33 | 771.67 | 7217 | 6392 | 1.1290 | 1.0811 | MN20160304_L01 | K18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 51.55 | 771.67 | 6400 | 6829 | 0.9371 | 0.9591 | MN20160304_L01 | D09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 51.55 | 771.67 | 7778 | 6829 | 1.1388 | 1.0844 | MN20160304_L01 | K18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 53.77 | 771.67 | 6743 | 7256 | 0.9293 | 0.9551 | MN20160304_L01 | D09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 53.77 | 771.67 | 8245 | 7256 | 1.1362 | 1.0806 | MN20160304_L01 | K18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 55.99 | 771.67 | 7085 | 7690 | 0.9213 | 0.9512 | MN20160304_L01 | D09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 55.99 | 771.67 | 8685 | 7690 | 1.1294 | 1.0747 | MN20160304_L01 | K18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 58.21 | 771.67 | 7436 | 8085 | 0.9197 | 0.9512 | MN20160304_L01 | D09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 58.21 | 771.67 | 9207 | 8085 | 1.1387 | 1.0781 | MN20160304_L01 | K18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 60.44 | 771.67 | 7867 | 8530 | 0.9222 | 0.9538 | MN20160304_L01 | D09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 60.44 | 771.67 | 9748 | 8530 | 1.1427 | 1.0785 | MN20160304_L01 | K18 |